(Q42910043)

English

Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise)

scientific article published in October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise). (English)

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1

object named as

Scott Metcalfe

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

author name string

Rachel Grocott

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Dilky Rasiah

3

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

publication date

1 October 2014

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

32

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

10

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1031-1033

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

11 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s40273-014-0208-0

0 references

Comments on "Simoens, S. Health economic assessment: a methodological primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966"-New Zealand in fact has no cost-effectiveness threshold

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Explicit incorporation of equity considerations into economic evaluation of public health interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

QALY maximisation and people's preferences: a methodological review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Resource allocation, social values and the QALY: a review of the debate and empirical evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Equity in health: the importance of different health streams

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to Harris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Double jeopardy and the veil of ignorance--a reply

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Double jeopardy and the use of QALYs in health care allocation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

16 August 2018

Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

16 August 2018

Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

16 August 2018

The Value of Thinly Spread QALYs

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0208-0

21 January 2018

QALYs and the equity-efficiency trade-off

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Our advice? Get a budget!

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reconciliation of Economic Concerns and Health Policy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How New Zealand has contained expenditure on drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40273-014-0208-0

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42910043&oldid=1860595255"